Madsen Chris D, Hooper Steven, Tozluoglu Melda, Bruckbauer Andreas, Fletcher Georgina, Erler Janine T, Bates Paul A, Thompson Barry, Sahai Erik
1] Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields London WC2A 3LY, UK [2] Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5 2200 Copenhagen N, Denmark.
Tumour Cell Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields London WC2A 3LY, UK.
Nat Cell Biol. 2015 Jan;17(1):68-80. doi: 10.1038/ncb3083. Epub 2014 Dec 22.
The contractile actomyosin cytoskeleton and its connection to the plasma membrane are critical for control of cell shape and migration. We identify three STRIPAK complex components, FAM40A, FAM40B and STRN3, as regulators of the actomyosin cortex. We show that FAM40A negatively regulates the MST3 and MST4 kinases, which promote the co-localization of the contractile actomyosin machinery with the Ezrin/Radixin/Moesin family proteins by phosphorylating the inhibitors of PPP1CB, PPP1R14A-D. Using computational modelling, in vitro cell migration assays and in vivo breast cancer metastasis assays we demonstrate that co-localization of contractile activity and actin-plasma membrane linkage reduces cell speed on planar surfaces, but favours migration in confined environments similar to those observed in vivo. We further show that FAM40B mutations found in human tumours uncouple it from PP2A and enable it to drive a contractile phenotype, which may underlie its role in human cancer.
收缩性肌动球蛋白细胞骨架及其与质膜的连接对于细胞形状和迁移的控制至关重要。我们鉴定出三种STRIPAK复合物成分,即FAM40A、FAM40B和STRN3,它们是肌动球蛋白皮质的调节因子。我们发现FAM40A负向调节MST3和MST4激酶,这两种激酶通过磷酸化PPP1CB、PPP1R14A - D的抑制剂,促进收缩性肌动球蛋白机制与埃兹蛋白/根蛋白/膜突蛋白家族蛋白的共定位。通过计算建模、体外细胞迁移试验和体内乳腺癌转移试验,我们证明收缩活性和肌动蛋白 - 质膜连接的共定位会降低细胞在平面表面上的速度,但有利于在类似于体内观察到的受限环境中迁移。我们进一步表明,在人类肿瘤中发现的FAM40B突变使其与PP2A解偶联,并使其能够驱动收缩表型,这可能是其在人类癌症中发挥作用的基础。